AIM ImmunoTech Inc.
AIM
$0.12
-$0.0034-2.76%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 190.00K | 201.00K | 193.00K | 202.00K | 193.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 190.00K | 201.00K | 193.00K | 202.00K | 193.00K |
| Cost of Revenue | 36.00K | 58.00K | 50.00K | 42.00K | 30.00K |
| Gross Profit | 154.00K | 143.00K | 143.00K | 160.00K | 163.00K |
| SG&A Expenses | 20.94M | 23.30M | 23.26M | 21.66M | 14.03M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 28.11M | 31.79M | 33.55M | 32.12M | 23.66M |
| Operating Income | -27.92M | -31.59M | -33.36M | -31.92M | -23.47M |
| Income Before Tax | -23.93M | -28.05M | -31.12M | -28.96M | -20.78M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -23.93 | -28.05 | -31.12 | -28.96 | -20.78 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -23.93M | -28.05M | -31.12M | -28.96M | -20.78M |
| EBIT | -27.92M | -31.59M | -33.36M | -31.92M | -23.47M |
| EBITDA | -27.68M | -31.36M | -33.11M | -31.68M | -23.12M |
| EPS Basic | -0.47 | -0.57 | -0.64 | -0.59 | -0.43 |
| Normalized Basic EPS | -0.30 | -0.36 | -0.40 | -0.37 | -0.27 |
| EPS Diluted | -0.48 | -0.57 | -0.64 | -0.60 | -0.43 |
| Normalized Diluted EPS | -0.30 | -0.36 | -0.40 | -0.37 | -0.27 |
| Average Basic Shares Outstanding | 208.86M | 199.82M | 195.39M | 194.34M | 193.53M |
| Average Diluted Shares Outstanding | 208.86M | 199.82M | 195.39M | 194.34M | 193.53M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
